Clinical trial
A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis
NCT00149201 · Japan Clinical Oncology Group, Other · Completed
Key facts
| NCT number | NCT00149201 |
|---|---|
| Title | A Study of 5-FU Versus MTX+5-FU in Gastric Cancer With Peritoneal Metastasis |
| Official title | Randomized Phase III Study of 5-FU Continuous Infusion (5FUci) Versus MTX+5-FU Sequential Therapy (MF) in Gastric Cancer With Peritoneal Metastasis (JCOG0106-MF, MF/5FU) |
| Lead sponsor | Japan Clinical Oncology Group, Other |
| Collaborators | Ministry of Health, Labour and Welfare, Japan |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastric Cancer, Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | 5-FU continuous infusion, MTX + 5-FU sequential therapy |
| Enrollment | 160 |
| Start date | Nov 1, 2002 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Sep 8, 2005 |
| Last update posted | Feb 3, 2009 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: